Filing Details

Accession Number:
0001127602-21-016798
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-05-14 16:04:31
Reporting Period:
2021-05-13
Accepted Time:
2021-05-14 16:04:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1221127 M. Lori Henderson C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
General Counsel And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-13 6,600 $14.85 7,501 No 4 M Direct
Common Stock Disposition 2021-05-13 6,600 $152.60 901 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-13 6,600 $0.00 6,600 $14.85
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
354,752 2028-06-26 No 4 M Direct
Footnotes
  1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on December 23, 2020.
  2. 25% of this option will vest and become exercisable on April 9, 2019 with the remainder vesting in 12 equal quarterly installments thereafter.